The Rise of Precision Medicine in Lung Cancer and the Role of the MDT

This episode explores the rapidly evolving landscape of lung cancer treatment, from the removal of stigma in general practice to the emergence of targeted therapies, immunotherapy, and precision medicine. The panel discusses the critical role of the multidisciplinary team — particularly cancer nurses — in treatment coordination, toxicity management, and patient education, with a focus on meeting patients where they are across diverse cultural, social, and clinical backgrounds. Hosted by Melanie Rabbets, Oncology Nurse Practitioner at Blacktown Cancer Care, Western Sydney, and joined by Associate Professor Mal Itchins, Medical Oncologist and trialist at Royal North Shore Hospital and Chris O'Brien Lifehouse, Sydney, and Dr Renae Grundy, Lung Cancer Clinical Nurse Consultant at Royal Hobart Hospital, Tasmania. Sponsored by Pfizer.